Family Preservation Services, Inc. Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 1027 Huddleston Dr, Huddleston, VA 24104 Phone: 434-528-9711 Fax: 434-528-9716 |
Family Preservation Services, Inc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 1027 Huddleston Dr, Huddleston, VA 24104 Phone: 434-528-9711 Fax: 434-528-9716 |
Family Preservation Services, Inc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 1027 Huddleston Road, Huddleston, VA 24014 Phone: 540-528-9711 Fax: 540-528-9716 |
News Archive
High blood glucose is associated with poor outcomes in hospitalized patients, and use of intensive insulin therapy (IIT) to control hyperglycemia is a common practice in hospitals. But the recent evidence does not show a consistent benefit and even shows harms associated with the use of IIT, according to the American College of Physicians' (ACP) Clinical Guidelines Committee in a new evidence-based paper published today online in the American Journal of Medical Quality.
CSL Behring today announced it has enrolled the first patient in COMPACT, an international phase III study of a volume-reduced, subcutaneous formulation of C1-esterase inhibitor oncentrate in patients with frequent hereditary angioedema attacks (NCT01912456).
An innovative treatment technology could give cancer patients new hope for survival. In an international study based at Lawson Health Research Institute and London Health Sciences Centre's London Regional Cancer Program (LRCP), scientists are testing a therapy with the potential to eradicate cancers previously thought to be incurable.
Researchers have developed a screening tool for identifying compounds that restore functionality of the protein that is dysfunctional in Alport syndrome.
› Verified 3 days ago